MDxHealth SA (OTCMKTS:MXDHF – Get Free Report) shares traded down 9.1% during mid-day trading on Tuesday . The stock traded as low as $0.25 and last traded at $0.25. 300 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Price Performance
The business’s 50 day moving average price is $0.43. The company has a debt-to-equity ratio of 1.45, a current ratio of 1.25 and a quick ratio of 1.19.
About MDxHealth
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Featured Stories
- Five stocks we like better than MDxHealth
- What Do S&P 500 Stocks Tell Investors About the Market?
- Comprehensive PepsiCo Stock Analysis
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Bear Market Funds to Watch This Year
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.
